 | • レポートコード：TPM-B04131 • 出版社/出版日：Transparency Market Research / 2017年12月 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、肺炎球菌ワクチンの世界市場について調べ、肺炎球菌ワクチンの世界規模、市場動向、市場環境、製品別分析、流通経路別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・肺炎球菌ワクチンの世界市場動向 ・肺炎球菌ワクチンの世界市場環境 ・肺炎球菌ワクチンの世界市場規模 ・肺炎球菌ワクチンの世界市場規模：製品別 ・肺炎球菌ワクチンの世界市場規模：流通経路別 ・肺炎球菌ワクチンの世界市場：地域別市場規模・分析 ・肺炎球菌ワクチンの北米市場規模・予測 ・肺炎球菌ワクチンのアメリカ市場規模・予測 ・肺炎球菌ワクチンの中南米市場規模・予測 ・肺炎球菌ワクチンのヨーロッパ市場規模・予測 ・肺炎球菌ワクチンのアジア市場規模・予測 ・肺炎球菌ワクチンの日本市場規模・予測 ・肺炎球菌ワクチンの中国市場規模・予測 ・肺炎球菌ワクチンのインド市場規模・予測 ・肺炎球菌ワクチンのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Pneumococcal Vaccines Market- Overview
The prevention of disease through vaccination is one of the most cost-effective and safe ways. Pneumococcus is one of the leading causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media. It is also one of the leading infectious diseases. However, it can be prevented with the help of vaccination. With an increase in pneumococcal disease due to causative serotype, the need for vaccines with broader coverage has increased. Hence, the demand for new pneumococcal vaccines with broader serotype coverage is increasing.
Despite the availability of antibiotic therapy against pneumococcal disease, it remains a significant cause of death among people with increased susceptibility, such as older adults and also the people suffering from immunosuppressive conditions or chronic illness. However, reduction in the pneumococcal disease has been witnessed in the countries that introduced pneumococcal conjugate vaccines (PCV). Meanwhile, efforts are underway to introduce pneumococcal vaccines in other countries as well. Companies are also working on introducing new and affordable PCVs, especially for developing countries. There has also been an increase in investment in the research and development activities to develop new vaccines at lower cost.
Global Pneumococcal Vaccines Market – Scope of Study
The research report on the global pneumococcal vaccines market offers key market insights and factors playing an important role in the market growth. The report provides information on market dynamics including trends, factors driving the market, opportunities, and restraints. Key developments in the market are also provided in the report. The report also offers analysis and forecast on various market segments and regions.
The report offers detailed study on the present and upcoming opportunities and developments along with advancement in technologies. Porter’s five force model along with SWOT analysis is also given in the report. The report has also evaluated market attractiveness. The global pneumococcal vaccines market displays the revenue, market share, growth rate for segments as well as regions.
The primary and secondary research has been done to offer both quantitative and qualitative data. The detail on leading players operating in the market along with the business strategies and new developments has also been provided in the report. Also covered in the report are regulations, ongoing research and developments in various countries. This will help the companies to make important business decisions to strengthen their position in the market.
Global Pneumococcal Vaccines Market- Key Segments
The global pneumococcal vaccines market is divided into product type, distribution channel, and region. Product type is further segmented into 7- valent PCV, 10- valent PCV, 13- valent PCV, and 23- valent PPSV. On the basis of distribution channel, the market is segmented into hospitals, clinics, and other distribution channels.
Region-wise, the market is segmented into Europe, Japan, Latin America, North America, Asia Pacific Excluding Japan (APEJ), and the Middle East and Africa (MEA). This segmentation also offers country-wise analysis on all the key parameters associated with the global pneumococcal vaccines market.
Global Pneumococcal Vaccines Market- Competitive Landscape
The report offers competitive landscape including vital information on some of the leading players contributing towards the market expansion. Some of the leading players operating in the market are Pfizer, Inc., GlaxoSmithKline PLC, Merck & Co. Inc., and Sanofi. The report offers detailed profile on each of the players including company overview, key strategies, financial overview, latest developments, and product portfolio.
レポート目次1. Global Economic Outlook
2. Global Pneumococcal Vaccines Market – Executive Summary
3. Global Pneumococcal Vaccines Market Overview
3.1. Introduction
3.1.1. Global Pneumococcal Vaccines Market Taxonomy
3.1.2. Global Pneumococcal Vaccines Market Definition
3.2. Global Pneumococcal Vaccines Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Pneumococcal Vaccines Market Y-o-Y Growth
3.3. Global Pneumococcal Vaccines Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. PESTL Analysis
3.8. Product Life Cycle Analysis
3.9. Epidemiology
3.10. Coverage Rates By Pneumococcal Conjugate Vaccines (PCV) Against Invasive Pneumococcal Disease In Children Of Different Age Groups
3.11. Key Regulations
3.12. PATENT
3.13. List of Distributors
3.14. Key Participants Market Presence (Intensity Map) By Region
4. Global Pneumococcal Vaccines Market Analysis and Forecast 2012-2026
4.1. Global Pneumococcal Vaccines Market Size and Forecast By Product Type, 2012-2026
4.1.1. 7- Valent PCV Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. 10- Valent PCV Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. 13- Valent PCV Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. 23- Valent PPSV Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.2. Global Pneumococcal Vaccines Market Size and Forecast By Distribution Channel, 2012-2026
4.2.1. Hospitals Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Clinics Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Other End Users Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
5. North America Pneumococcal Vaccines Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Product Type
5.6. Revenue (US$ Mn) Comparison, By Distribution Channel
6. Latin America Pneumococcal Vaccines Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Product Type
6.6. Revenue (US$ Mn) Comparison, By Distribution Channel
7. Europe Pneumococcal Vaccines Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Product Type
7.6. Revenue (US$ Mn) Comparison, By Distribution Channel
8. Japan Pneumococcal Vaccines Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Product Type
8.6. Revenue (US$ Mn) Comparison, By Distribution Channel
9. APEJ Pneumococcal Vaccines Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Product Type
9.6. Revenue (US$ Mn) Comparison, By Distribution Channel
10. MEA Pneumococcal Vaccines Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Product Type
10.6. Revenue (US$ Mn) Comparison, By Distribution Channel
11. Global Pneumococcal Vaccines Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
11.3.1. Pfizer, Inc.
11.3.2. GlaxoSmithKline PLC
11.3.3. Merck & Co., Inc.
11.3.4. Sanofi
11.4. Key Takeaways
12. Research Methodology
13. Disclaimer
List of TablesTABLE 1 Global Pneumococcal Vaccines Market Value (US$ Mn), 2012-2017
TABLE 2 Global Pneumococcal Vaccines Market Value (US$ Mn), 2018-2026
TABLE 3 Global Pneumococcal Vaccines Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global 7- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global 7- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global 7- Valent PCV Segment Market Share, By Region 2012-2017
TABLE 7 Global 7- Valent PCV Segment Market Share, By Region 2018-2026
TABLE 8 Global 7- Valent PCV Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global 10- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global 10- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global 10- Valent PCV Segment Market Share, By Region 2012-2017
TABLE 12 Global 10- Valent PCV Segment Market Share, By Region 2018-2026
TABLE 13 Global 10- Valent PCV Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global 13- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global 13- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global 13- Valent PCV Segment Market Share, By Region 2012-2017
TABLE 17 Global 13- Valent PCV Segment Market Share, By Region 2018-2026
TABLE 18 Global 13- Valent PCV Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global 23- Valent PPSV Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global 23- Valent PPSV Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global 23- Valent PPSV Segment Market Share, By Region 2012-2017
TABLE 22 Global 23- Valent PPSV Segment Market Share, By Region 2018-2026
TABLE 23 Global 23- Valent PPSV Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Hospitals Segment Market Share, By Region 2012-2017
TABLE 27 Global Hospitals Segment Market Share, By Region 2018-2026
TABLE 28 Global Hospitals Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Clinics Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Clincs Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Clincs Segment Market Share, By Region 2012-2017
TABLE 32 Global Clincs Segment Market Share, By Region 2018-2026
TABLE 33 Global Clincs Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Other End Users Segment Market Share, By Region 2012-2017
TABLE 37 Global Other End Users Segment Market Share, By Region 2018-2026
TABLE 38 Global Other End Users Segment Y-o-Y, By Region 2017-2026
TABLE 39 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 40 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 41 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 42 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 43 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 44 North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 45 North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 46 North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 47 North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 48 North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 49 North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 50 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 51 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 52 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 53 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 54 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 55 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 56 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 57 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 58 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 59 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 60 Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 61 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 62 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 63 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 64 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 65 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 66 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 67 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 68 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 69 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 70 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 71 Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 72 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 73 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 74 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 75 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 76 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 77 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 78 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 79 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 80 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 81 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 82 Japan Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 83 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 84 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 85 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 86 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 87 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 88 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 89 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 90 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 91 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 92 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 93 APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 94 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 95 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 96 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 97 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 98 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 99 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
TABLE 100 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
TABLE 101 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
TABLE 102 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
TABLE 103 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 104 MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026